Vigor Medical Technologies Overview
Vigor Medical Technologies develops lifesaving devices for treating chest trauma and thoracic/abdominal drainage. The company's flagship product, the C-Lant self-fixation sealing device, is designed to prevent lung and heart collapse. C-Lant can be used by emergency medical services, first aid organizations, and hospital ER, trauma, thoracic/abdominal surgery, and pulmonary departments.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
The Israeli development that can save soldiers on the battlefield and those injured in road accidents
ויגור מדיקל, חברה ישראלית, קיבלה השקעה ממשרד הביטחון, הטכניון והרשות לחדשנות, במטרה להפחית את התמותה מפגיעות חזה בכ-75% מהמקרים. כחמישית מהפצועים בשדה הקרב ובתאונות דרכים סובלים מפגיעות חזה, המחייבות טיפול דחוף בשטח. הפיתוח של החברה עשוי לשנות את המצב הנוכחי שבו פצועים קל הופכים לפצועים בינוני-קשה, ופצועים קשה עלולים למות. החברה קוראת לציבור להצטרף להשקעה.
Investment
growth-positive
A simple invention that can save millions of lives
Vigor Medical Technologies has developed a revolutionary device for treating chest traumas, which can be administered by ambulance teams, potentially saving numerous lives. The device simplifies the procedure, reducing complications and costs compared to existing methods. Founded by Irina Kavounovski, Igor Waysbeyn, and investor Dr. John Abeles, Vigor is in the final stages of product development and aims to enter the U.S. and European markets. The company has received a €2.5M grant from the EIC and expects an additional €7.2M in funding. Vigor is also seeking $1.5-2.0MM in complementary funding. The company is part of the IN-VENTech startup program, which supports its business development and fundraising efforts.
InvestmentPartners
growth-positive
Novel device boosts survival chances after chest trauma
Vigor Medical Technologies, an Israeli company, has developed a self-fixation sealing device called C-Lant that can prevent lung and heart collapse in chest trauma patients. The device, which has won several awards and competitions, is a simple and effective alternative to current treatment methods. Vigor Medical Technologies is seeking $1 million in funding through OurCrowd. The company plans to conduct its first clinical trial at the end of the year and aims to obtain CE marketing approval in Europe. The device has the potential to be used in various types of trauma and surgeries.
InvestmentPartners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $2.6M |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 4 |
| Investors | 1 |
Team Members
4
Employees: 1-10
Web & Social Links
| Website | www.vigormt.com |
Locations
Tabenkin Street 16, Haifa, Israel
Photos & Videos
4 item(s)
